澳大利亚脑膜炎球菌监测计划年度报告,2024年
Monica Lahra1, Siobhan Hurley2, C R Robert George3
1NSW Health Pathology World Health Organisation Collaborating Centre for STI and AMR, Sydney and Neisseria Reference Laboratory, Department of Microbiology, The Prince of Wales Hospital, Randwick, 2031, NSW Australia; School of Medical Sciences, Faculty of Medicine, The University of New South Wales, NSW, 2052 Australia . monica.lahra@health.nsw.gov.au.
Communicable diseases intelligence (2018)
|November 17, 2025
概括
在2024年,侵袭性脑膜炎球菌病 (IMD) 报告在澳大利亚下降了5%. 血清组B (MenB) 主导,特别是在儿童和年轻人中,大多数分离物对关键抗生素敏感.
科学领域:
- 流行病学 流行病学
- 微生物学 微生物学
- 公共卫生 公共卫生
背景情况:
- 侵入性脑膜炎球菌病 (IMD) 是澳大利亚的一个重大公共卫生问题.
- 对IMD的监测对于了解疾病趋势和指导公共卫生干预至关重要.
研究的目的:
- 报告2024年澳大利亚侵入性脑膜炎球菌病 (IMD) 病例的流行病学和实验室特征.
- 分析血清组分布,抗菌素易感性和IMD的人口模式.
主要方法:
- 数据是通过国家可报告疾病监测系统 (NNDSS) 收集的.
- 使用细菌培养和核酸放大测试进行实验室确认.
- 血清组的确定,porA细型,和抗菌感应性测试 (AST) 的分离物.
主要成果:
- 与2023年相比,IMD通知减少了5%,报告了136起案件.
- 血清组B (MenB) 是主要的血清组 (84%),其次是MenY (14%).
- 在5岁以下的儿童和15-24岁的年轻成年人中发生的发病率最高,两个群体都占主导地位. 在7%的分离物体中观察到青素耐药性,在60%的分离物体中观察到中间敏感性.
结论:
- 侵袭性脑膜炎球菌病 (IMD) 仍然是一个问题,而MenB是主要的驱动因素.
- 年龄特定的发病率突出显示了针对性监测和潜在干预的关键人群.
- 虽然大多数隔离物仍然对セフtriaxone,西普罗夫洛克萨和利芬素敏感,但正在演变的青素耐药性模式需要持续监测.
相关概念视频
01:26Principles of Disease Surveillance
444
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
444
01:19Pharmacovigilance
1.6K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.6K